Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target by Fundamental Research Analysts

Zepp Health (NYSE:ZEPP) has been assigned a $13.87 price objective by equities research analysts at Fundamental Research in a research report issued on Tuesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Fundamental Research’s price target would suggest a potential upside of 417.54% from the company’s previous close.

Zepp Health Trading Up 2.3 %

ZEPP opened at $2.68 on Tuesday. The company has a quick ratio of 0.87, a current ratio of 1.21 and a debt-to-equity ratio of 0.13. The stock’s fifty day moving average is $2.84 and its two-hundred day moving average is $2.97. The company has a market capitalization of $40.34 million, a P/E ratio of -1.07 and a beta of 0.71. Zepp Health has a 52 week low of $2.06 and a 52 week high of $4.38.

Institutional Trading of Zepp Health

An institutional investor recently bought a new position in Zepp Health stock. Mandatum Life Insurance Co Ltd purchased a new stake in Zepp Health Co. (NYSE:ZEPP) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,750 shares of the company’s stock, valued at approximately $28,000. Mandatum Life Insurance Co Ltd owned approximately 0.07% of Zepp Health as of its most recent filing with the SEC. Institutional investors and hedge funds own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.